61177-44-4 | Lithium Clavulanate

Introduction
Clavulanate lithium is a highly effective β-lactamase inhibitor and can be used as an antibiotic.

Specification of CAS: 61177-44-4 lithium clavulanate

Target: β-lactamase

In vitro studies:

Clavulanate lithium has weak antibacterial activity against most organisms when administered alone, but given in combination with beta-lactam antibiotics prevents antibiotic inactivation by microbial lactamase.

Clavulanate lithium (0.25, 0.5 mg/L) causes a relatively slow inhibition of growth, and a higher concentration (1 mg/L) is only marginally more effective than 0.5 mg/L.

Hot Tags: 61177-44-4 | lithium clavulanate, price, quotation, discount, in stock, for sale, Pharmaceutical Intermediates, Biochemicals